KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Treasury Shares (2020 - 2025)

Clover Health Investments' Treasury Shares history spans 5 years, with the latest figure at $86.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 178.1% year-over-year to $86.2 million; the TTM value through Dec 2025 reached $86.2 million, up 178.1%, while the annual FY2025 figure was $86.2 million, 178.1% up from the prior year.
  • Treasury Shares reached $33.4 million in Q4 2025 per CLOV's latest filing, down from $38.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $38.0 million in Q3 2025 to a low of -$5.1 million in Q1 2025.
  • Average Treasury Shares over 5 years is $11.7 million, with a median of $7.5 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: skyrocketed 4327.89% in 2022, then skyrocketed 55.95% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $147000.0 in 2021, then surged by 4327.89% to $6.5 million in 2022, then soared by 95.56% to $12.7 million in 2023, then surged by 143.47% to $31.0 million in 2024, then soared by 178.1% to $86.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Treasury Shares are $86.2 million (Q4 2025), $77.0 million (Q3 2025), and $71.4 million (Q2 2025).